Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers [Phase 2]
Phase 2 trial evaluating ponatinib in lung cancer patients preselected by predictive biomarkers; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC) [Phase 1]
Phase 1 clinical trial update of a monoclonal antibody therapy for progressive small cell lung cancer has completed recruitment with results…
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy [Phase 1, Phase 2]
Clinical trial updates on a combination of olaparib and temozolomide in recurrent small cell lung cancer after prior chemotherapy failure (P…
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: Hippocampus Avoidance PCI vs PCI [Phase 3]
Phase 3 clinical trial comparing hippocampus-avoidance prophylactic cranial irradiation (PCI) to standard PCI in small cell lung cancer and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial update evaluating safety, tolerability, and preliminary efficacy of JK1201I in patients with Small Cell Lung …
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers [Phase 1, Phase 2]
Phase 1/2 trial update for PEN-221 in somatostatin receptor 2 expressing advanced cancers, including neuroendocrine tumors and small cell lu…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Camrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer [Phase 2]
Phase 2 trial investigating camrelizumab plus apatinib as maintenance therapy in extensive-stage small cell lung cancer; status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) [Phase 2]
Phase 2 trial exploring pembrolizumab with chemotherapy with or without radiation in small cell lung cancer has terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine and nivolumab as subsequent-line therapy for metastatic small cell lung cancer; study status terminated…
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). [Phase 1]
Phase 1 study evaluating venetoclax with atezolizumab, carboplatin, and etoposide in untreated extensive-stage small cell lung cancer was te…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial investigating pegzilarginase in combination with pembrolizumab for extensive-disease small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer [Phase 3]
Phase 3 trial comparing Lurbinectedin/Doxorubicin against CAV or Topotecan in small-cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer [Phase 2]
Phase II trial evaluating novel combinations for platinum-refractory extensive-stage small cell lung cancer; the study is completed and resu…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy in extensive-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient [Phase 3]
Phase 3 trial update for belotecan/cisplatin in chemotherapy-naive small cell lung cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy [Phase 2]
A Phase 2 trial evaluating the combination of simvastatin and irinotecan in extensive-stage small cell lung cancer patients who relapsed aft…
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy [Phase 2]
Phase 2 trial exploring the combination of simvastatin and albumin-bound paclitaxel for extensive-stage small cell lung cancer (ES-SCLC) in …
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC [Phase 2]
Phase II study evaluating sintilimab plus anlotinib in extensive-stage small cell lung cancer is underway (details currently unknown).
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating tremelimumab and durvalumab with or without radiation therapy in relapsed small cell lung cancer has completed and …
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating Fluzopalil in combination with Anlotinib for extensive small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for AL8326 in Small Cell Lung Cancer spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating SHR-1701 with and without famitinib in extensive-stage small cell lung cancer (SCLC).
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC [Phase 3]
Phase 3 trial update comparing accelerated hypofractionated versus conventionally fractionated concurrent chemoradiation for limited-stage s…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies [Phase 2]
Phase 2 trial update evaluating PDR001 plus LAG525 in patients with advanced solid and hematologic malignancies; results posted with complet…